News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Applovin Corp (APP) stock declined by 3.56% on July 22, influenced by a broader cooling in the high-growth technology sector and shifting macroeconomic indicators, particularly concerns over the Federal Reserve's hawkish stance. Institutional selling, technical factors, and worries about increased competition in mobile ad-tech …
Sharemaestro market context Price below Trend Line 52 weeks -34.7%Clover Health's Medicare Advantage CEO, Jamie L. Reynoso, sold 4,839 shares of CLOV stock for $21,920, at a weighted average price of $4.53 per share, according to a Rule 10b5-1 trading plan. This transaction occurred after Clover Health shares surged 73% in six months, …
The Lovesac Company (NASDAQ:LOVE) has received a consensus "Moderate Buy" rating from brokerages, with an average 1-year price target of $22.67. Recent analyst actions have been mixed but generally positive, including target increases and upgrades. Insider buying activity, particularly by Director Andrew R. Heyer, …
Lovesac director Vineet Mehra sold 5,000 common shares on July 17, 2026, for $18.38 each, totaling $91,909. This transaction reduced his direct stake to 17,992 shares. The information was generated by AI based on an SEC filing by Lovesac Company.
Jamie L. Reynoso, CEO of Clover Health Medicare Advantage, sold 4,839 Class A common shares on July 17, 2026, for a total of $21,920.67 at a price of $4.53 per share. Following this transaction, Reynoso's direct stake in Clover Health fell to 2.81 million …
AppLovin director Webb Maynard G Jr was granted 41 restricted stock units (RSUs) on July 15, 2026, which vested immediately. Following this transaction, he directly holds 3,198 Class A shares, with an additional 120,444 Class A shares held indirectly through Webb Investment Network. The …
Sharemaestro market context Price below Trend Line 52 weeks -34.7%Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (CLOV), sold 4,839 shares of Class A Common Stock on July 17, 2026. The shares were sold at a weighted average price of $4.53 per share, ranging from $4.35 to $4.63, as …
AppLovin Corp director Barbara Messing was granted 40 restricted stock units (RSUs) of Class A common stock on July 15, 2026. These RSUs immediately vested on the grant date, and each represents a contingent right to receive one share of Class A common stock, …
Lovesac Co director Vineet Mehra sold 5,000 shares of common stock on July 17, 2026, at an average price of $18.3817 per share. Following this transaction, Mehra directly holds 17,992 shares of Lovesac common stock. The sale, valued at approximately $92,000, was not conducted …
Clover Health's interim CFO, Joseph Clay, sold 4,630 shares of Class A Common Stock on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a mandatory "sell-to-cover" transaction to satisfy tax withholding obligations related to the vesting of …
Clover Health CEO Andrew Toy sold 62,711 shares of Class A Common Stock for approximately $292,860 on July 15, 2026. This sale was non-discretionary, made to cover tax withholding obligations associated with the vesting of restricted stock units. Despite the sale, Toy still directly …
AppLovin Director Barbara Messing received 40 shares of Class A common stock on July 15, 2026, through a restricted stock unit grant, with no monetary consideration. This transaction increased her direct beneficial ownership to 10,190 shares. The disclosure on July 17, 2026, highlights the …
This article is a Form 144 filing for Lovesac Co, dated July 16. It is published by Investing.com, which also includes disclaimers about the high risks involved in trading financial instruments and cryptocurrencies. The content emphasizes that data provided is not necessarily real-time or …
A shareholder of Lovesac Co. (LOVE) has filed a Form 144 indicating an intent to sell up to 15,000 shares of common stock, valued at $249,150.00, through Morgan Stanley Smith Barney LLC on Nasdaq on July 16, 2026. The filing also details recent employee …
Conrad Wai, CEO of Counterpart Health at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 24,215 shares of the company’s Class A Common Stock for $113,084. This sale was a "sell to cover" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock …
Clover Health Investments CEO Andrew Toy sold 62,711 Class A shares at a weighted average price of $4.67 per share. This mandatory "sell to cover" transaction was executed to fulfill tax withholding obligations tied to the vesting of 6.25% of his restricted stock units …
Clover Health Investments' Chief Legal Officer, Karen Soares, sold 10,519 shares of Class A common stock at a weighted average price of $4.67 per share on July 15, 2026. This transaction was to cover tax withholding obligations from the vesting of restricted stock units …
Clover Health insider Wai Conrad sold 24,215 Class A shares on July 15, 2026, at a weighted average price of $4.67 per share. This sale was a non-discretionary "sell to cover" transaction to satisfy tax withholding obligations from the vesting of 6.25% of his …
An affiliate of Clover Health Investments (Nasdaq: CLOV) plans to sell 12,712 Class A common shares, valued at $59,492.16, through Morgan Stanley Smith Barney LLC around July 15, 2026. These shares originated from restricted stock units granted as compensation. The filing also notes previous …
Clover Health Investments, Corp. (Nasdaq: CLOV) has filed a Form 144 notice for the planned sale of 60,765 shares of Class A Common Stock. These shares originate from Restricted Stock Units granted as compensation and are scheduled to be sold on Nasdaq via Morgan …
Clover Health Investments, Corp. (CLOV) has filed a Form 144 disclosing a planned sale of 23,463 shares of Class A Common Stock with an aggregate market value of $109,806.84 through Morgan Stanley Smith Barney LLC on July 15, 2026. These shares originated from restricted …
Search by ticker symbol or company name and select a result to open its chart.